CVS Health (NYSE:CVS) said Thursday that it sees sales growth accelerating as it expands the services it offers at its drugstores and people’s homes to make health care more affordable and easier for customers.
The drugstore chain and health insurer is sharing its strategy at its first investor day since the start of the pandemic and since the company’s new CEO Karen Lynch stepped into the top role.
Lynch told investors CVS will build on changes in consumer habits and the trust it gained during the pandemic, as people used telehealth and turned to drugstores for COVID tests and vaccines. She said
CVS is uniquely positioned to help fix a broken health-care system that frustrates customers and keeps increasing in cost yet often delivers poor outcomes.
"The market is ripe for change that only we can deliver," she said.
CVS is weaving together its numerous drugstores, pharmacy benefit manager Caremark and insurance company Aetna to try to drive more business.
On Thursday, the company said it will lay out details of its plans for new health products and services, including subscription models and home health care. It said it will share details about how it can reduce costs and improving health outcomes for people with chronic conditions like diabetes and congestive heart disease, such as those who have Aetna insurance and fill prescriptions at CVS pharmacies.
Shares opened Thursday up $1.79, or 1.9%, to $94.89.
